PURPOSE: Limited robust randomised controlled trials investigating fruit and vegetable (F&V) intake in people at risk of cardiovascular disease (CVD) exist. We aimed to design and validate a dietary strategy of increasing flavonoid-rich versus flavonoid-poor F&V consumption on nutrient biomarker profile. METHODS: A parallel, randomised, controlled, dose-response dietary intervention study. Participants with a CVD relative risk of 1.5 assessed by risk scores were randomly assigned to one of the 3 groups: habitual (control, CT), high-flavonoid (HF) or low-flavonoid (LF) diets. While the CT group (n = 57) consumed their habitual diet throughout, the HF (n = 58) and LF (n = 59) groups sequentially increased their daily F&V intake by an additional 2, 4 and 6 portions for 6-week periods during the 18-week study. RESULTS: Compliance to target numbers and types of F&V was broadly met and verified by dietary records, and plasma and urinary biomarkers. Mean (± SEM) number of F&V portions/day consumed by the HF and LF groups at baseline (3.8 ± 0.3 and 3.4 ± 0.3), 6 weeks (6.3 ± 0.4 and 5.8 ± 0.3), 12 weeks (7.0 ± 0.3 and 6.8 ± 0.3) and 18 weeks (7.6 ± 0.4 and 8.1 ± 0.4), respectively, was similar at baseline yet higher than the CT group (3.9 ± 0.3, 4.3 ± 0.3, 4.6 ± 0.4, 4.5 ± 0.3) (P = 0.015). There was a dose-dependent increase in dietary and urinary flavonoids in the HF group, with no change in other groups (P = 0.0001). Significantly higher dietary intakes of folate (P = 0.035), non-starch polysaccharides (P = 0.001), vitamin C (P = 0.0001) and carotenoids (P = 0.0001) were observed in both intervention groups compared with CT, which were broadly supported by nutrient biomarker analysis. CONCLUSIONS: The success of improving nutrient profile by active encouragement of F&V intake in an intervention study implies the need for a more hands-on public health approach.
RCT Entities:
PURPOSE: Limited robust randomised controlled trials investigating fruit and vegetable (F&V) intake in people at risk of cardiovascular disease (CVD) exist. We aimed to design and validate a dietary strategy of increasing flavonoid-rich versus flavonoid-poor F&V consumption on nutrient biomarker profile. METHODS: A parallel, randomised, controlled, dose-response dietary intervention study. Participants with a CVD relative risk of 1.5 assessed by risk scores were randomly assigned to one of the 3 groups: habitual (control, CT), high-flavonoid (HF) or low-flavonoid (LF) diets. While the CT group (n = 57) consumed their habitual diet throughout, the HF (n = 58) and LF (n = 59) groups sequentially increased their daily F&V intake by an additional 2, 4 and 6 portions for 6-week periods during the 18-week study. RESULTS: Compliance to target numbers and types of F&V was broadly met and verified by dietary records, and plasma and urinary biomarkers. Mean (± SEM) number of F&V portions/day consumed by the HF and LF groups at baseline (3.8 ± 0.3 and 3.4 ± 0.3), 6 weeks (6.3 ± 0.4 and 5.8 ± 0.3), 12 weeks (7.0 ± 0.3 and 6.8 ± 0.3) and 18 weeks (7.6 ± 0.4 and 8.1 ± 0.4), respectively, was similar at baseline yet higher than the CT group (3.9 ± 0.3, 4.3 ± 0.3, 4.6 ± 0.4, 4.5 ± 0.3) (P = 0.015). There was a dose-dependent increase in dietary and urinary flavonoids in the HF group, with no change in other groups (P = 0.0001). Significantly higher dietary intakes of folate (P = 0.035), non-starch polysaccharides (P = 0.001), vitamin C (P = 0.0001) and carotenoids (P = 0.0001) were observed in both intervention groups compared with CT, which were broadly supported by nutrient biomarker analysis. CONCLUSIONS: The success of improving nutrient profile by active encouragement of F&V intake in an intervention study implies the need for a more hands-on public health approach.
Authors: Hagen Schroeter; Christian Heiss; Jan Balzer; Petra Kleinbongard; Carl L Keen; Norman K Hollenberg; Helmut Sies; Catherine Kwik-Uribe; Harold H Schmitz; Malte Kelm Journal: Proc Natl Acad Sci U S A Date: 2006-01-17 Impact factor: 11.205
Authors: K J Joshipura; F B Hu; J E Manson; M J Stampfer; E B Rimm; F E Speizer; G Colditz; A Ascherio; B Rosner; D Spiegelman; W C Willett Journal: Ann Intern Med Date: 2001-06-19 Impact factor: 25.391
Authors: D O McCall; C P McGartland; M C McKinley; P Sharpe; D R McCance; I S Young; J V Woodside Journal: Nutr Metab Cardiovasc Dis Date: 2010-04-13 Impact factor: 4.222
Authors: David Vauzour; Emily J Houseman; Trevor W George; Giulia Corona; Roselyne Garnotel; Kim G Jackson; Christelle Sellier; Philippe Gillery; Orla B Kennedy; Julie A Lovegrove; Jeremy P E Spencer Journal: Br J Nutr Date: 2009-11-30 Impact factor: 3.718
Authors: Sara Neshatdoust; Caroline Saunders; Sophie M Castle; David Vauzour; Claire Williams; Laurie Butler; Julie A Lovegrove; Jeremy P E Spencer Journal: Nutr Healthy Aging Date: 2016-10-27
Authors: Francesco Vitali; Rosario Lombardo; Damariz Rivero; Fulvio Mattivi; Pietro Franceschi; Alessandra Bordoni; Alessia Trimigno; Francesco Capozzi; Giovanni Felici; Francesco Taglino; Franco Miglietta; Nathalie De Cock; Carl Lachat; Bernard De Baets; Guy De Tré; Mariona Pinart; Katharina Nimptsch; Tobias Pischon; Jildau Bouwman; Duccio Cavalieri Journal: Genes Nutr Date: 2018-04-30 Impact factor: 5.523
Authors: Alanna J McGrath; Lesley L Hamill; Chris R Cardwell; Claire R Draffin; Charlotte E Neville; Katherine M Appleton; Jane McEneny; Michelle C McKinley; Ian S Young; Jayne V Woodside Journal: Eur J Nutr Date: 2015-06-17 Impact factor: 5.614
Authors: Susan J Duthie; Garry G Duthie; Wendy R Russell; Janet A M Kyle; Jennie I Macdiarmid; Vanessa Rungapamestry; Sylvia Stephen; Cristina Megias-Baeza; Joanna J Kaniewska; Lindsey Shaw; Lesley Milne; David Bremner; Karen Ross; Philip Morrice; Lynn P Pirie; Graham Horgan; Charles S Bestwick Journal: Eur J Nutr Date: 2017-05-30 Impact factor: 5.614